Divisadero Street Capital Management LP Buys New Shares in ZimVie Inc. (NASDAQ:ZIMV)

Divisadero Street Capital Management LP bought a new position in ZimVie Inc. (NASDAQ:ZIMV - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 29,969 shares of the company's stock, valued at approximately $418,000. Divisadero Street Capital Management LP owned approximately 0.11% of ZimVie as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently made changes to their positions in the company. Bank of New York Mellon Corp lifted its holdings in shares of ZimVie by 0.9% during the fourth quarter. Bank of New York Mellon Corp now owns 100,638 shares of the company's stock valued at $1,404,000 after purchasing an additional 943 shares in the last quarter. Rhumbline Advisers raised its position in ZimVie by 3.0% in the 4th quarter. Rhumbline Advisers now owns 45,214 shares of the company's stock worth $631,000 after buying an additional 1,303 shares during the last quarter. SG Americas Securities LLC raised its position in ZimVie by 15.7% in the 4th quarter. SG Americas Securities LLC now owns 11,110 shares of the company's stock worth $155,000 after buying an additional 1,508 shares during the last quarter. Principal Financial Group Inc. lifted its stake in ZimVie by 9.8% during the 4th quarter. Principal Financial Group Inc. now owns 19,054 shares of the company's stock valued at $266,000 after acquiring an additional 1,702 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its holdings in shares of ZimVie by 8.2% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 24,571 shares of the company's stock valued at $343,000 after acquiring an additional 1,852 shares during the last quarter. Institutional investors own 95.63% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. B. Riley began coverage on shares of ZimVie in a report on Thursday, April 10th. They set a "buy" rating and a $16.00 price objective for the company. Needham & Company LLC reaffirmed a "hold" rating on shares of ZimVie in a research report on Wednesday, April 9th.

ZimVie Stock Performance

ZimVie stock traded up $0.16 during mid-day trading on Monday, reaching $8.92. 124,888 shares of the stock traded hands, compared to its average volume of 214,755. ZimVie Inc. has a 12-month low of $8.56 and a 12-month high of $22.40. The business's 50-day moving average is $10.32 and its 200-day moving average is $12.63. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.94 and a quick ratio of 1.38. The stock has a market capitalization of $248.40 million, a PE ratio of -0.68 and a beta of 2.16.

ZimVie (NASDAQ:ZIMV - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $0.27 EPS for the quarter. The firm had revenue of $112.00 million during the quarter, compared to analyst estimates of $113.10 million. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. As a group, sell-side analysts predict that ZimVie Inc. will post 0.6 EPS for the current fiscal year.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.